Search
for
Sort by
Research 991–1000 of 1000+
- Dermatologic adverse events in pediatric patients receiving targeted anticancer therapies: A pooled analysis
- Degradable co-delivery nanoplatforms for inflammation-targeted therapy against atherosclerosis
- Developing a JAK Inhibitor for Targeted Local Delivery: Ruxolitinib Cream
- Cutaneous adverse reactions linked to targeted anticancer therapies bortezomib and lenalidomide for multiple myeloma: new drugs, old side effects
- Basal Cell Carcinoma, Hedgehog Signaling, and Targeted Therapeutics: The Long and Winding Road
- Catamenial-like seizure exacerbation in mice with targeted ablation of extrasynaptic δGABA-a receptors in the brain
- Platelet-rich plasma as a site-targeted approach in wound healing: a molecular perspective
- Methodologies to Evaluate the Hair Follicle-Targeted Drug Delivery Provided by Nanoparticles
- Safety and efficacy of advanced and targeted acid α-glucosidase (AT-GAA) (ATB200/AT2221) in ERT-switch nonambulatory patients with Pompe disease: preliminary results from the ATB200-02 trial
- Niosomes as Efficient Nanocarriers for Targeted Drug Delivery